Search Results  for '600789.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shandong Lukang Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Shandong Lukang Pharmaceutical Co Ltd (600789-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Jun 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Shandong Lukang Pharmaceutical

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

02 Jun 2016 Wright Reports 61 $75.00

Thomson Reuters Stock Report - Shandong Lukang Pharmaceutical Co Ltd (600789-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Shandong Lukang Pharmaceutical Co., Ltd: Downgraded to Risky

09 Mar 2016 Sadif Analytics Prime 3 $10.00

Shandong Lukang Pharmaceutical Co., Ltd: Upgraded to Average

15 Dec 2015 Sadif Analytics Prime 3 $10.00

Shandong Lukang Pharmaceutical Co., Ltd: Downgraded to Risky

09 Oct 2015 Sadif Analytics Prime 3 $10.00

Shandong Lukang Pharmaceutical Co., Ltd: Downgraded to Below Average

22 Jan 2015 Sadif Analytics Prime 3 $10.00

Is Shandong Lukang Pharmaceutical Co., Ltd Still a Bargain?

03 Nov 2014 Sadif Analytics Prime 12 $25.00

Will Shandong Lukang Pharmaceutical Co., Ltd Deliver Top-Shelf Performance?

11 Aug 2014 Sadif Analytics Prime 12 $25.00